Functional imaging of tumor proteolysis.

The roles of proteases in cancer are now known to be much broader than simply degradation of extracellular matrix during tumor invasion and metastasis. Furthermore, proteases from tumor-associated cells (e.g., fibroblasts, inflammatory cells, endothelial cells) as well as tumor cells are recognized to contribute to pathways critical to neoplastic progression. Although elevated expression (transcripts and proteins) of proteases, and in some cases protease inhibitors, has been documented in many tumors, techniques to assess functional roles for proteases require that we measure protease activity and inhibition of that activity rather than levels of proteases, activators, and inhibitors. Novel techniques for functional imaging of protease activity, both in vitro and in vivo, are being developed as are imaging probes that will allow us to determine protease activity and in some cases to discriminate among protease activities. These should be useful clinically as surrogate endpoints for therapies that alter protease activities.

[1]  Bonnie F. Sloane,et al.  Cathepsin B: association with plasma membrane in metastatic tumors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[2]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[3]  Bonnie F. Sloane,et al.  Unraveling the role of proteases in cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[4]  A. Köhler,et al.  Comparative Localization of Cathepsin B Protein and Activity in Colorectal Cancer , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  Y. DeClerck Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. , 2000, European journal of cancer.

[6]  X. Puente,et al.  Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.

[7]  E. Bröcker,et al.  Release of cell fragments by invading melanoma cells. , 2004, European journal of cell biology.

[8]  C. López-Otín,et al.  Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. , 2004, The International journal of developmental biology.

[9]  P. Richardson,et al.  Proteasome inhibition as a novel therapeutic target in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Bonnie F. Sloane,et al.  Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. , 1994, The American journal of pathology.

[11]  James P. Quigley,et al.  Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer , 2003, Cancer and Metastasis Reviews.

[12]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[13]  E. Sahai,et al.  Integrin β1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo , 2004, British Journal of Cancer.

[14]  Bonnie F. Sloane,et al.  Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. , 1994, The American journal of pathology.

[15]  Bonnie F. Sloane,et al.  Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. , 2000, Biochimica et biophysica acta.

[16]  S. Leppla,et al.  Potent antitumor activity of a urokinase-activated engineered anthrax toxin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Khokha,et al.  Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development , 2003, British Journal of Cancer.

[18]  Bonnie F. Sloane,et al.  Imaging Proteolysis by Living Human Glioma Cells , 2001, Biological chemistry.

[19]  K. Danø,et al.  Stromal cell expression of components of matrix-degrading protease systems in human cancer. , 1996, Enzyme & protein.

[20]  V. Giranda,et al.  The protease consortium: An alliance to advance the understanding of proteolytic enzymes as therapeutic targets for cancer , 1999, Molecular Carcinogenesis.

[21]  D. Cunningham,et al.  Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignancies. , 2003, Critical reviews in oncology/hematology.

[22]  L. Matrisian,et al.  Molecular imaging of proteolytic activity in cancer , 2003, Journal of cellular biochemistry.

[23]  Ralph Weissleder,et al.  Near-infrared optical imaging of proteases in cancer. , 2003, Molecular cancer therapeutics.

[24]  Kinneret Keren,et al.  Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.

[25]  L. Lund,et al.  Plasminogen activation and cancer , 2005, Thrombosis and Haemostasis.

[26]  Jeffrey W. Smith,et al.  A Unique Substrate Recognition Profile for Matrix Metalloproteinase-2* , 2002, The Journal of Biological Chemistry.

[27]  M. Noguchi,et al.  Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. , 1999, Cancer research.

[28]  C. Overall,et al.  Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics , 2002, Biological chemistry.

[29]  Bonnie F. Sloane,et al.  Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. , 1994, Journal of cell science.

[30]  Peter Friedl,et al.  Functional imaging of pericellular proteolysis in cancer cell invasion. , 2005, Biochimie.

[31]  Bonnie F. Sloane,et al.  Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. , 2003, Molecular imaging.

[32]  R. Weissleder,et al.  Optical zymography for specific detection of urokinase plasminogen activator activity in biological samples. , 2005, Analytical biochemistry.

[33]  B. Nielsen,et al.  Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[34]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[35]  Erik Sahai,et al.  Mechanisms of cancer cell invasion. , 2005, Current opinion in genetics & development.

[36]  Ralph Weissleder,et al.  Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment. , 2002, Neoplasia.

[37]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[38]  Ralph Weissleder,et al.  Design, synthesis, and characterization of urokinase plasminogen-activator-sensitive near-infrared reporter. , 2004, Chemistry & biology.

[39]  J. Brugge,et al.  Use of Three-Dimensional Basement Membrane Cultures to Model Oncogene-Induced Changes in Mammary Epithelial Morphogenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.

[40]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[41]  Bonnie F. Sloane,et al.  Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix. , 2000, Experimental cell research.

[42]  D. Corey,et al.  Optimal Subsite Occupancy and Design of a Selective Inhibitor of Urokinase* , 1997, The Journal of Biological Chemistry.

[43]  Bonnie F. Sloane,et al.  Cathepsin B and D are localized at the surface of human breast cancer cells , 2008, Pathology & Oncology Research.

[44]  M. Bernardo,et al.  Regulation of membrane type-matrix metalloproteinases. , 2002, Seminars in cancer biology.

[45]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[46]  Vijaya Iragavarapu-Charyulu,et al.  T cell-derived matrix metalloproteinase-9 in breast cancer: friend or foe? , 2004, Breast disease.

[47]  J. Parsons,et al.  Local degradation of fibronectin at sites of expression of the transforming gene product pp60src , 1985, Nature.

[48]  Bonnie F. Sloane,et al.  Cysteine cathepsins in human cancer , 2004, Biological chemistry.

[49]  Bonnie F. Sloane,et al.  Imaging proteolysis by living human breast cancer cells. , 2000, Neoplasia.

[50]  Bonnie F. Sloane,et al.  Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. , 2005, Seminars in cancer biology.

[51]  Matthew Bogyo,et al.  Activity-based probes that target diverse cysteine protease families , 2005, Nature chemical biology.

[52]  Bonnie F. Sloane,et al.  Human Procathepsin B Interacts with the Annexin II Tetramer on the Surface of Tumor Cells* , 2000, The Journal of Biological Chemistry.

[53]  J. Saurat,et al.  Differential protease expression by cutaneous squamous and basal cell carcinomas. , 1991, The Journal of clinical investigation.

[54]  D. Corey,et al.  Distinguishing the Specificities of Closely Related Proteases , 1997, The Journal of Biological Chemistry.

[55]  Mina J Bissell,et al.  Modeling tissue-specific signaling and organ function in three dimensions , 2003, Journal of Cell Science.

[56]  L. Matrisian,et al.  Tumor progression: Defining the soil round the tumor seed , 2001, Current Biology.

[57]  Shiva Gautam,et al.  Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. , 2004, The Biochemical journal.

[58]  Bonnie F. Sloane,et al.  Degradation of laminin by human tumor cathepsin B , 1989, Clinical & Experimental Metastasis.

[59]  Ralph Weissleder,et al.  Protease sensors for bioimaging , 2003, Analytical and bioanalytical chemistry.

[60]  N. Behrendt The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/ Endo180): membrane proteins engaged in matrix turnover during tissue remodeling , 2004, Biological chemistry.

[61]  S Toba,et al.  Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. , 2000, Chemistry & biology.

[62]  R. Smith,et al.  Use of different derivatives ofd-Val-Leu-Arg for studying kallikrein activities in cat submandibular glands and saliva , 1985, The Histochemical Journal.

[63]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[64]  Bonnie F. Sloane Suicidal tumor proteases , 1996, Nature Biotechnology.

[65]  B. Nielsen,et al.  Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy , 2005, The Journal of cell biology.

[66]  Smith Re,et al.  The use of amino acid derivatives of 4-methoxy-beta-naphthylamine for the assay and subcellular localization of tissue proteinases. , 1975 .

[67]  C. Blobel,et al.  ADAMs: key components in EGFR signalling and development , 2005, Nature Reviews Molecular Cell Biology.

[68]  G. Giannelli,et al.  Cancer Invasion: Watch Your Neighbourhood! , 2003, Tumori.

[69]  S. Leppla,et al.  Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin* , 2001, The Journal of Biological Chemistry.

[70]  Bonnie F. Sloane,et al.  Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles , 1983, Clinical & Experimental Metastasis.

[71]  Bonnie F. Sloane,et al.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. , 1992, The Biochemical journal.

[72]  Bonnie F. Sloane,et al.  Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. , 2005, Neoplasia.

[73]  M. Stack,et al.  Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[74]  P. Friedl,et al.  Proteolytic and non-proteolytic migration of tumour cells and leucocytes. , 2003, Biochemical Society symposium.

[75]  Bonnie F. Sloane,et al.  Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells , 2005, Journal of Cell Science.

[76]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.